Shanghai Historical Cash Flow
| 688293 Stock | 42.98 0.20 0.47% |
Analysis of Shanghai OPM cash flow over time is an excellent tool to project Shanghai OPM Biosciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 31.4 M or Other Non Cash Items of 8.5 M as it is a great indicator of Shanghai OPM ability to facilitate future growth, repay debt on time or pay out dividends.
Shanghai |
About Shanghai Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Shanghai balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Shanghai's non-liquid assets can be easily converted into cash.
Shanghai OPM Cash Flow Chart
Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Shanghai OPM Biosciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Shanghai OPM operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Shanghai OPM's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Shanghai OPM Biosciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shanghai OPM Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Shanghai OPM's Begin Period Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Other Non Cash Items is expected to grow to about 8.5 M, whereas Change To Inventory is forecasted to decline to (5.9 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Other Non Cash Items | 9.1M | 7.9M | 8.2M | 8.5M | Depreciation | 28.2M | 33.8M | 36.8M | 31.4M |
Shanghai OPM cash flow statement Correlations
Click cells to compare fundamentals
Shanghai OPM Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
Other Information on Investing in Shanghai Stock
The Cash Flow Statement is a financial statement that shows how changes in Shanghai balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Shanghai's non-liquid assets can be easily converted into cash.